The stock market performance of Corbus Pharmaceuticals Holdings Inc has been very steady. Over the last year, the company’s stock hit its highest at $61.90 on 07/31/24, while the lowest price during the same time frame was $5.87, recorded on 01/18/24.
52-week price history of CRBP Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Corbus Pharmaceuticals Holdings Inc’s current trading price is -80.74% away from its 52-week high, while its distance from the 52-week low is 103.01%. The stock’s price range for this period has remained between $5.87 and $61.90. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.19 million for the day, which was noticeably lower compared to the shares’ average daily volume of 0.31 million over the last three months.
Financial Performance and Market Capitalization
Corbus Pharmaceuticals Holdings Inc (CRBP) has experienced a quarterly decline of -37.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 145.18M and boasts a workforce of 19 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 23.28, with a change in price of -47.78. Similarly, Corbus Pharmaceuticals Holdings Inc recorded 518,164 in trading volume during the last 100 days, posting a change of -80.03%.
CRBP Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CRBP stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
CRBP Stock Stochastic Average
As of today, the raw stochastic average of Corbus Pharmaceuticals Holdings Inc over the past 50 days is 9.23%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 27.27%. Additionally, the Stochastic %K and %D values for the company were 41.21% and 31.20%, respectively, over the past 20 days.
CRBP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 1.02% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -77.52%. Over the past 30 days, the price of CRBP has leaped by -16.53%. And in the last five days, it has surged by 1.10%.
